The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
US says it thwarted potential IS-inspired New Year's Eve attack
Swiss face painful task of identifying victims of deadly fire
Hiker killed in rare suspected mountain lion attack in Colorado
Contaminated water kills 9 and hospitalises 200 in India's Indore city
Several reported killed in Iran protests
